JP2004500315A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004500315A5 JP2004500315A5 JP2000554761A JP2000554761A JP2004500315A5 JP 2004500315 A5 JP2004500315 A5 JP 2004500315A5 JP 2000554761 A JP2000554761 A JP 2000554761A JP 2000554761 A JP2000554761 A JP 2000554761A JP 2004500315 A5 JP2004500315 A5 JP 2004500315A5
- Authority
- JP
- Japan
- Prior art keywords
- afp
- reversible complex
- equilibrium
- equilibrium reversible
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002441 reversible effect Effects 0.000 description 17
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 206010061598 Immunodeficiency Diseases 0.000 description 6
- 208000029462 Immunodeficiency disease Diseases 0.000 description 6
- 230000007813 immunodeficiency Effects 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical class CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 101000848653 Homo sapiens Tripartite motif-containing protein 26 Proteins 0.000 description 1
- KWKZCGMJGHHOKJ-ZKWNWVNESA-N Methyl Arachidonyl Fluorophosphonate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCP(F)(=O)OC KWKZCGMJGHHOKJ-ZKWNWVNESA-N 0.000 description 1
- PZPHIQQEQWCEGG-DOFZRALJSA-N Phospho-anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCOP(O)(O)=O PZPHIQQEQWCEGG-DOFZRALJSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 102000046101 human AFP Human genes 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000004235 neutropenia Diseases 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9802162A SE9802162D0 (sv) | 1998-06-17 | 1998-06-17 | Immunostimulating composition |
| PCT/EP1999/004201 WO1999065936A2 (en) | 1998-06-17 | 1999-06-17 | Composition for the treatement of immune deficiencies and methods for its preparation and use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004500315A JP2004500315A (ja) | 2004-01-08 |
| JP2004500315A5 true JP2004500315A5 (https=) | 2006-08-03 |
| JP4392991B2 JP4392991B2 (ja) | 2010-01-06 |
Family
ID=20411743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000554761A Expired - Fee Related JP4392991B2 (ja) | 1998-06-17 | 1999-06-17 | 免疫不全症の処置のための組成物、およびその調製と使用のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6599507B2 (https=) |
| EP (1) | EP1085909B1 (https=) |
| JP (1) | JP4392991B2 (https=) |
| AT (1) | ATE314094T1 (https=) |
| AU (1) | AU748838B2 (https=) |
| BR (1) | BR9911294B1 (https=) |
| CA (1) | CA2335079C (https=) |
| DE (1) | DE69929189T2 (https=) |
| SE (1) | SE9802162D0 (https=) |
| WO (1) | WO1999065936A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9802162D0 (sv) | 1998-06-17 | 1998-06-17 | Nomet Management Services Bv | Immunostimulating composition |
| SE9900941D0 (sv) * | 1998-12-23 | 1999-03-16 | Nomet Management Serv Bv | Novel retinoic acid derivatives and their use |
| CA2358436C (en) * | 1999-03-16 | 2009-03-10 | Ardenia Investments Ltd. | Polyunsaturated fatty acid derivatives and their use |
| US6699851B2 (en) | 2000-07-12 | 2004-03-02 | Ardenia Investments, Ltd. | Cytotoxic compounds and their use |
| US20070111936A1 (en) * | 2005-11-15 | 2007-05-17 | Vladimir Pak | Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096863A (en) * | 1996-08-23 | 2000-08-01 | Regents Of The University Of Minnesota | Self-assembling amphiphiles for construction of peptide secondary structures |
| SE9802162D0 (sv) | 1998-06-17 | 1998-06-17 | Nomet Management Services Bv | Immunostimulating composition |
-
1998
- 1998-06-17 SE SE9802162A patent/SE9802162D0/xx unknown
-
1999
- 1999-06-17 JP JP2000554761A patent/JP4392991B2/ja not_active Expired - Fee Related
- 1999-06-17 EP EP99931090A patent/EP1085909B1/en not_active Expired - Lifetime
- 1999-06-17 AU AU47734/99A patent/AU748838B2/en not_active Ceased
- 1999-06-17 BR BRPI9911294-9A patent/BR9911294B1/pt not_active IP Right Cessation
- 1999-06-17 WO PCT/EP1999/004201 patent/WO1999065936A2/en not_active Ceased
- 1999-06-17 CA CA002335079A patent/CA2335079C/en not_active Expired - Fee Related
- 1999-06-17 DE DE69929189T patent/DE69929189T2/de not_active Expired - Lifetime
- 1999-06-17 AT AT99931090T patent/ATE314094T1/de not_active IP Right Cessation
-
2000
- 2000-12-15 US US09/738,704 patent/US6599507B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0828499B1 (en) | Micro-encapsulated lactobacilli for medical applications | |
| AU2007345952C1 (en) | Positively charged water-soluble prodrugs of 1H-imidazo[4, 5-c]quinolin-4-amines and related compounds with very high skin penetration rates | |
| US6174873B1 (en) | Oral administration of adenosine analogs | |
| JP4024852B2 (ja) | 「経皮吸収製剤」 | |
| JP4021507B2 (ja) | プロリン含有医薬組成物 | |
| ES2649063T3 (es) | Formulaciones farmacéuticas que contienen rifaximina, procedimientos para su obtención y método de tratamiento de la enfermedad intestinal | |
| CA2446435A1 (en) | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives | |
| RU95107881A (ru) | Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата | |
| JPH10503522A (ja) | 化学療法剤とともに使用するための防御性プロスタグランジン | |
| JP2002528502A5 (https=) | ||
| ES2173641T3 (es) | Composicion de derivados opiaceos para la fabricacion de medicamentos. | |
| BR9807319A (pt) | Microgrânulos com liberação controlada, para administração oral, contendo cisplatina, processo de preparação dos mesmos, preparação farmacêutica, e, utilização dos microgrânulos. | |
| JP2002526407A5 (https=) | ||
| WO2000041504A3 (en) | Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| JPH10511944A (ja) | スーパーオキシドジスムターゼ含有医薬組成物 | |
| JPH0152370B2 (https=) | ||
| RU2001121650A (ru) | Композиции для лечения кожных заболеваний | |
| PL327323A1 (en) | Orally administered 5-asa containing pharmaceutic composition of modified active substance release and method of treating intestinal diseases | |
| JP2003514025A5 (https=) | ||
| CA2032475A1 (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
| JP2004500315A5 (https=) | ||
| JPS63145279A (ja) | 医薬品生成物 | |
| WO2000016786A3 (en) | Oxihumic acid and its use in the treatment of various conditions | |
| RU2401104C2 (ru) | Фармацевтическая композиция на основе тилорона местного и наружного применения для лечения гнойно-деструктивных поражений слизистой и кожи, общесистемных заболеваний при иммунодефицитных состояниях |